美国 · 财经报刊 · Investor's Business Daily
Merck Beats, But Can Shares Outplay The Cancer Vaccine News?
Dow Jones component Merck hiked its 2026 outlook Thursday on the back of a solid third-quarter report that included a notable Keytruda beat. The post Merck Beats, But Can Shares…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
